Targeted Medical Pharma   Report issue

For profit Phase 3 Phase 4
Founded: Los Angles CA United States (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2008
NCT01468038
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Vincent Martin, MD

Active Ingredients

Drugs in Phase 4 Trials (2)

histamine (4 trials)

ibuprofen (motrin) (1 trial)

Drugs in Phase 3 Trials (4)

amino acids (Freamine) (1 trial)

naproxen (naprosyn) (1 trial)

trazamine (1 trial)

trazodone (desyrel) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Back Pain (Phase 4)

Headache (Phase 4)

Low Back Pain (Phase 4)

Migraine Disorders (Phase 4)

Parasomnias (Phase 3)

Sleep Wake Disorders (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 6